News Releases

PHILADELPHIA – A study led by Penn Medicine researchers found that childhood trauma is linked to abnormal connectivity in the brain in adults with major depressive disorder (MDD).

A study using cloud-computing to track and display brain activity in real-time for the potential treatment of depression has netted Penn Medicine, Princeton University, Yale University and Intel Corporation with a Fierce Innovation Award.

Penn Medicine is announcing the newest Translational Center of Excellence (TCE) in the Abramson Cancer Center, focused on Glioblastoma Multiforme, the most common and lethal form of brain cancer. The team will investigate new immune therapies for glioblastoma and, in particular, design and test new CAR T cell therapies.

Today, a slate of guidelines to shape the future of Parkinson’s biomarker research have been published in Science Translational Medicine.

Reduced levels of plasmalogens—a class of lipids created in the liver that are integral to cell membranes in the brain—are associated with an increased risk of Alzheimer’s Disease, according to new research presented this week at the Alzheimer’s Association International Conference (AAIC) 2018 by Mitchel A. Kling, MD, an associate professor of Psychiatry in the Perelman School of Medicine at the University of Pennsylvania and the Veterans Affairs Medical Center.